On Invalid Date, Jaguar Health (NASDAQ: JAGX) reported Q1 2024 earnings per share (EPS) of -$3.60, up 97.49% year over year. Total Jaguar Health earnings for the quarter were -$9.23 million. In the same quarter last year, Jaguar Health's earnings per share (EPS) was -$143.40.
As of Q2 2024, Jaguar Health's earnings has grown year over year. Jaguar Health's earnings in the past year totalled -$38.32 million.
What is JAGX's earnings date?
Jaguar Health's earnings date is Invalid Date. Add JAGX to your watchlist to be reminded of JAGX's next earnings announcement.
What was JAGX's revenue last quarter?
On Invalid Date, Jaguar Health (NASDAQ: JAGX) reported Q1 2024 revenue of $2.35 million up 19.22% year over year. In the same quarter last year, Jaguar Health's revenue was $1.97 million.
What was JAGX's revenue growth in the past year?
As of Q2 2024, Jaguar Health's revenue has grown -10.29% year over year. This is 87.52 percentage points lower than the US Biotechnology industry revenue growth rate of 77.23%. Jaguar Health's revenue in the past year totalled $10.14 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.